NRCA
Pharmaceutical ManufacturingCanada51-200 Employees
Learn about working at NRCA. Join LinkedIn today for free. See who you know at NRCA, leverage your professional network, and get hired.
Market Position NRCA operates within the pharmaceutical manufacturing industry with a substantial revenue range of 250 to 500 million dollars, indicating a solid market presence and potential budget for procurement of advanced manufacturing or operational technology solutions.
Technology Adoption The company's use of diverse digital tools such as Hotjar, LiveChat, and modern UI components suggests an openness to integrating innovative digital solutions, opening opportunities for advanced analytics, customer engagement platforms, or automation services.
Growth Potential With a mid-sized workforce of 51 to 200 employees, NRCA is likely in a growth or scaling phase, making it a strategic target for solutions supporting expansion, efficiency improvements, or workforce management.
Industry Trends Aligned with similar companies like Firestone Building Products and Masco Corporation, NRCA could benefit from solutions tailored to the pharmaceutical manufacturing sector's evolving needs, such as regulatory compliance, quality assurance, or supply chain management.
Networking Opportunities Active engagement on professional platforms like LinkedIn indicates potential for relationship-building and direct outreach strategies, enabling sales teams to connect with key decision-makers in the pharmaceutical manufacturing space.
NRCA uses 8 technology products and services including Hotjar, Modernizr, Floating UI, and more. Explore NRCA's tech stack below.
| NRCA Email Formats | Percentage |
| FLast@nrca.net | 86% |
| Last@nrca.net | 8% |
| FirstLast@nrca.net | 3% |
| F.Last@nrca.net | 3% |
Pharmaceutical ManufacturingCanada51-200 Employees
Learn about working at NRCA. Join LinkedIn today for free. See who you know at NRCA, leverage your professional network, and get hired.
NRCA's revenue is estimated to be in the range of $250M$500M
NRCA's revenue is estimated to be in the range of $250M$500M